Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia.
about
The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivoLoss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation.Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes.The tumor suppressor p15Ink4b regulates the differentiation and maturation of conventional dendritic cells.Sox4 cooperates with CREB in myeloid transformationThe role of tumor suppressor p15Ink4b in the regulation of hematopoietic progenitor cell fate.Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis.The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe?Concise review: erythroid versus myeloid lineage commitment: regulating the master regulators.Epigenetics of myelodysplastic syndromes.The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes.New Insights into the Pathogenesis of MDS and the rational therapeutic opportunities.Effects of Novel ncRNA Molecules, p15-piRNAs, on the Methylation of DNA and Histone H3 of the CDKN2B Promoter Region in U937 Cells.The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemia.Macrophage-Restricted Shp2 Tyrosine Phosphatase Acts as a Rheostat for MMP12 through TGF-β Activation in the Prevention of Age-Related Emphysema in Mice.CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid LeukemiaA combination of STI571 and BCR-ABL1 siRNA with overexpressed p15INK4B induced enhanced proliferation inhibition and apoptosis in chronic myeloid leukemia.Brief report: Loss of p15Ink4b accelerates development of myeloid neoplasms in Nup98-HoxD13 transgenic mice.
P2860
Q28507164-568FC5AA-B603-4C10-92E7-4BF2374F1EC2Q30415442-1C97076A-4311-4B6F-B683-0A1CA0E7A83DQ34754281-E4CFFC10-23F7-4313-885C-A4D6690BC95DQ36010305-CAAFC902-5CBD-4C02-AF02-45910D74BEE5Q36079778-FB0E54A5-8236-484E-A94D-37C64AC3A7EEQ36566573-1E246A52-7F67-41C2-9656-1B4087C9F19EQ38053346-9EAC110D-7AD0-42AB-AB72-17252E7D9F5DQ38068040-39943A1A-3ED5-4EBF-88B3-3F09BB2327BDQ38096321-01E8641D-E2FF-4E5F-9066-E85993693E97Q38163846-369BF3E0-8A47-4A0B-8E59-434DD4EA389AQ38570399-AB03691C-5FE7-4D7D-9210-ADBB4313B795Q38687894-179517CC-E871-4C61-A586-B2D618FDE1DFQ38849898-493BAEAB-CF6E-4689-A5CF-33481491772BQ38977867-26D4A634-6B65-4923-A5E3-484770C3D4CBQ40091029-DB1D3976-906A-4923-B42E-03B911A7F017Q41429764-A977D530-F00E-4DD3-8F2F-E1C2C32BD46BQ42195868-ABFE5C62-BD02-4312-A8B0-F20D1D0558A3Q54383073-52742637-7E9A-4324-8DA8-32A313013A42
P2860
Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Myeloid-specific inactivation ...... sposition to myeloid leukemia.
@ast
Myeloid-specific inactivation ...... sposition to myeloid leukemia.
@en
Myeloid-specific inactivation ...... sposition to myeloid leukemia.
@nl
type
label
Myeloid-specific inactivation ...... sposition to myeloid leukemia.
@ast
Myeloid-specific inactivation ...... sposition to myeloid leukemia.
@en
Myeloid-specific inactivation ...... sposition to myeloid leukemia.
@nl
prefLabel
Myeloid-specific inactivation ...... sposition to myeloid leukemia.
@ast
Myeloid-specific inactivation ...... sposition to myeloid leukemia.
@en
Myeloid-specific inactivation ...... sposition to myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
Myeloid-specific inactivation ...... sposition to myeloid leukemia.
@en
P2093
Joanna Fares
Juraj Bies
Linda Wolff
Marek Sramko
Michael Rosu-Myles
Richard Koller
Steven Zhang
P2860
P304
P356
10.1182/BLOOD-2009-08-238360
P407
P577
2010-05-10T00:00:00Z